The 51 contraceptive products, including the controversial Implanon and Implanon NXT, that were covered by the temporary restraining order (TRO) of the Supreme Court, have been determined to be non-abortifacient, or cannot cause abortion, by the Food and Drug Administration (FDA). In Advisory No. 2017-302 dated Nov. 11, 2017, the FDA said it has already concluded the re-evaluation of…Details
- Consultancy service
- ANC Services
- Immunization Services
- Routine Medical check-ups
- Specialized Clinics
- Screening and Testing
- HIV/Aids and STI programme
- Lifestyle Management Program
- Stress Management Program
- Chronic Disease Management Program
- Corporate Health-Talk Program
- Hospital wards
Our inpatient experts are well trained to give you around the clock medical expertise.
We offer high quality outpatient services because your health matters to us
Our labs are equipped with state of the art equipment.
We have the best quality of medicine available at very affordable prices.
It is increasingly acknowledged that the global gender gap is severe, with major negative economic and social consequences, and that accelerating progress toward gender parity has enormous benefits. Yet progress has been slow. One answer is collaborations — partnerships for parity — but they have to be put together carefully if they are to be…Details
New Report on Global Family Planning Charts Increase in Voluntary Use of Contraceptives by Women and Girls in the World’s Poorest Countries
Family Planning 2020’s (FP2020) annual progress report, launched today, charts progress in 2017 towards enabling 120 million more women and girls in the world’s poorest countries to use modern contraceptives by the year 2020. As of July 2017, more than 309 million women and girls in the 69 FP2020 focus countries are using a modern…Details